Six-monthly diabetes monitoring of well-controlled patients: experiences of primary care providers

Prim Care Diabetes. 2013 Oct;7(3):187-91. doi: 10.1016/j.pcd.2013.04.005. Epub 2013 May 7.

Abstract

Aims: To examine experiences of primary care providers with six-monthly diabetes monitoring of well-controlled patients.

Methods: This study was part of the EFFIMODI study, examining whether six-monthly monitoring of well-controlled (HbA1c ≤58 mmol/mol, systolic blood pressure ≤145 mmHg and total cholesterol ≤5.2 mmol/l) type 2 diabetes patients results in equivalent cardiometabolic control compared to three-monthly monitoring. Primary care providers completed a questionnaire about their experiences with six-monthly diabetes monitoring, whether they want to continue six-monthly monitoring and for which type of patients six-monthly monitoring is sufficient.

Results: Of 163 questionnaires, 157 (96.3%) were completed and returned. Only 14 (8.9%) primary care providers were negative about the six-monthly monitoring and 102 (65.0%) would like to continue six-monthly monitoring. Primary care providers disagreed about patients' ability to determine their own monitoring frequency and whether six-monthly monitoring was suitable for all well-controlled type 2 diabetes patients. Practical concerns emerged such as the inability to declare healthcare costs and the unsuitability of electronic health record systems.

Conclusions: Almost two out of three primary care providers would like to continue six-monthly monitoring of well-controlled type 2 diabetes patients. However, some diabetes care providers should be convinced and some practical concerns should be solved.

Keywords: Diabetes mellitus; Diabetes monitoring; Patient preference; Primary health care; Type 2.

Publication types

  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Attitude of Health Personnel
  • Biomarkers / blood
  • Blood Glucose / metabolism*
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / diagnosis
  • Diabetes Mellitus, Type 2 / therapy*
  • Eligibility Determination
  • Glycated Hemoglobin A / metabolism*
  • Health Care Surveys
  • Health Knowledge, Attitudes, Practice
  • Humans
  • Netherlands
  • Patient Preference
  • Practice Patterns, Physicians'
  • Predictive Value of Tests
  • Primary Health Care*
  • Surveys and Questionnaires
  • Time Factors
  • Treatment Outcome

Substances

  • Biomarkers
  • Blood Glucose
  • Glycated Hemoglobin A
  • hemoglobin A1c protein, human